Skip to main content
Omega-3 ingredient supplier focuses on tailored chemistry

Multinational KD Pharma has acquired a new British manufacturing site that will expand their base for production of active pharmaceutical precursors for the omega-3 market, especially substances customized to a buyer's need. "Multiple technologies exist for fractionating lipids that operate off of different chemistry principles, so having a wider technology portfolio allows us to find the most efficient path to isolate specific fatty acids, like EPA and DHA, based on the characteristics of the raw material coming in and the finished product we want to make," said Adam Ismail, chief strategy officer.

Full Story: